Authors


Mark L. Rohrbaugh, PhD

Latest:

NIH Offers Licensing Agreements to Commercialize Technologies

NIH makes available a full range of licenses for commercial evaluation and for the sale of commercial products and services.


Simon A. Rothen

Latest:

Developing and Manufacturing Attenuated Live Bacterial Vaccines

There are a number of specific characteristics to be considered when developing and manufacturing live bacterial vaccines.


Rakhi Rashmi

Latest:

Biopharmaceuticals in India: Evolving from Generics to Innovator Drugs

The new patent regime is challenging the Indian biopharm industry to transition from generics to novel products.


Michiel E. Ultee, PhD

Latest:

Implications of Cell Culture Conditions on Protein Glycosylation

The authors present a review of the techniques commonly used for glycosylation analysis.


George Colindres

Latest:

Trends in Convertible Note Financing for Biotechs

As more biotechs turn to convertible note financing instead of traditional venture capital, they need to be aware of investors' demands.


Sandy Sargis

Latest:

Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies

Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.


Darren Hieber

Latest:

Connecting the Manufacturing Process to Patient Wellness

Manufacturers of biopharmaceuticals can improve productivity by taking patient wellness into account.


Alan Shaw, PhD

Latest:

Vaccines Incorporating Toll-Like Receptor Ligands

This article discusses the production process of the major influenza antigen, hemagglutinin (HA), by rDNA methods in E. coli.




Timothy R.M. Bryant

Latest:

Royalty Interest Investing: Addressing the Out-License Assignability Issue

Several legal considerations are key to protect the buyer and seller in royalty interest transactions.


Wai Wong

Latest:

Integrating Risk Management as an Effective Approach to Root Cause Analysis

Optimize time and cost of product development by managing risk.


Shwu-Maan Lee, PhD

Latest:

Meningitis Vaccine Manufacturing: Fermentation Harvest Procedures Affect Purification

Careful analysis of an unusual precipitate identifies defects.



Akos Bartha, PhD

Latest:

Upgrading a Pharmaceutical Laboratory to Part 11 Compliance

FDA's regulation 21 CFR Part 11 on Electronic Records and Electronic Signatures provides industry with the requirements that allow electronic records and signatures in computerized systems in place of paper records and handwritten signatures.1



Philip Engel

Latest:

Modeling of Biopharmaceutical Processes. Part 2: Process Chromatography Unit Operation

A review of some recent contributions in process chromatography.


Joe Jovero

Latest:

Devising an International Clinical Trial Distribution Strategy: Genentech's Approach

A decision-criteria matrix and cost models helped pinpoint the best distribution approach for the short- and long-term.



Mark Berge

Latest:

Leveraging Fermentation Heat Transfer Data to Better Understand Metabolic Activity

A simple method to leverage fermentation heat transfer data.


Judy Glynn

Latest:

Advances in Monoclonal Antibody Purification

New technologies and adaptations of existing technologies can improve platform processes.


Magnus Stering

Latest:

Failure Mode Effects Analysis for Filter Integrity Testing

Understanding of the risks associated with FMEA is crucial in lot release testing.


Frank B. Gelder, PhD

Latest:

The Therapeutic Vaccine Potential of MIS416 Adjuvant

This article discusses the potential of MIS416 adjuvant, a vaccine adjuvant and immunogen co-delivery system, to provide adequate immunostimulation to overcome host factors that may limit the success of therapeutic vaccines.





Jorgen M. Mollerup

Latest:

Modeling of Biopharmaceutical Processes. Part 2: Process Chromatography Unit Operation

A review of some recent contributions in process chromatography.


Sharon X. Chen

Latest:

Solutions for Purification of Fc-fusion Proteins

When platform processes are applied to fusion molecules, innovation and flexibility are needed.



© 2025 MJH Life Sciences

All rights reserved.